TI
EXAS

tru Independence’s Exact Sciences EXAS Stock Holding History

tru Independence’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,091
Closed -$407K – 307
2021
Q1 		$407K Buy
3,091
+28
+0.9% +$3.83K 0.08% 185
2020
Q4 		$406 Buy
3,063
+3
+0.1% +$363 ﹤0.01% 391
2020
Q3 		$312K Hold
3,060
– – 0.09% 139
2020
Q2 		$266 Buy
+3,060
New +$244K 0.04% 218

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

tru Independence's EXAS Position: Q2 2021 in Review

tru Independence sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 3,091 shares — an estimated $407K sold.

tru Independence first reported a position in EXAS in Q2 2020 and held it in 4 quarters. The position peaked at $407K in Q1 2021. 622 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

  • tru Independence reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
  • tru Independence sold 3,091 Exact Sciences shares in Q2 2021, an estimated $407K.
  • tru Independence first reported a position in Exact Sciences in Q2 2020 and held it in 4 quarters.
  • tru Independence's Exact Sciences position peaked at $407K in Q1 2021.
  • 622 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on tru Independence's 13F filing for Q2 2021, filed 3 Aug 2021.